Posters: Infectious Disease/ PTLD and Malignancy Posters - from P2.63 to P2.73
Saturday September 20, 2025 from 17:40 to 18:40
MOA 10 (Exhibit Area)
Lectures
-
P2.63 Long-term follow up for pediatric kidney transplant recipients receiving IVIG for polyoma BK viremiaJessica Brennan, United States
-
P2.64 Status of EB virus antibody titer acquisition and EBV-DNA quantification values after pediatric renal transplantationProf. Yuko Hamasaki, Japan
-
P2.65 Sepsis and disseminated primary varicella in a vaccinated multivisceral transplant recipient New abstract created on Monday April 7, 2025Julie Iglesias, United States
-
P2.66 Efficacy of cidofovir and intravenous immunoglobin in pediatric renal transplant patients with BK viremiaElizabeth Ingulli, United States
-
P2.67 Outcome of severe COVID-19 infection in paediatric renal transplant recipientsDr. Camille Laroche, Canada
-
P2.68 Fungal Foes: A Decade of Antifungal Practices in Pediatric Lung TransplantDr. Sruti Nadimpalli, United States
-
P2.69 Maribavir for refractory cytomegalovirus infection in a child after combined liver and kidney transplantationDr. Małgorzata Panek, Poland
-
P2.70 EBV DNAemia Following Rituximab Treatment: Insights from a Case SeriesDr. Auda M. Plaud Gonzalez, Puerto Rico
-
P2.71 Unconventional immunotherapy in a case of pediatric EBV+ T-cell PTLD with concurrent EBV-associated smooth muscle tumor: A 14-year sustained remissionDr. Evgenia Preka, France
-
P2.72 Cytomegalovirus infection in first year after pediatric renal transplantation: a ten year single center experienceDr. Maria Teresa Ludovica Viganoni, Italy
-
P2.73 Post-transplant lymphoproliferative disorder – Case report with pediatric kidney transplantMs. Vy Thi Tuong Vo, Viet Nam